BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23832674)

  • 1. NMR assignments of PI3-SH3 domain aided by protonless NMR spectroscopy.
    Hsu ST
    Biomol NMR Assign; 2014 Oct; 8(2):291-5. PubMed ID: 23832674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution MAS NMR analysis of PI3-SH3 amyloid fibrils: backbone conformation and implications for protofilament assembly and structure .
    Bayro MJ; Maly T; Birkett NR; Macphee CE; Dobson CM; Griffin RG
    Biochemistry; 2010 Sep; 49(35):7474-84. PubMed ID: 20707313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of disulfide bonds to stability, folding, and amyloid fibril formation: the PI3-SH3 domain case.
    Graña-Montes R; de Groot NS; Castillo V; Sancho J; Velazquez-Campoy A; Ventura S
    Antioxid Redox Signal; 2012 Jan; 16(1):1-15. PubMed ID: 21797671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding kinetics of the SH3 domain of PI3 kinase by real-time NMR combined with optical spectroscopy.
    Guijarro JI; Morton CJ; Plaxco KW; Campbell ID; Dobson CM
    J Mol Biol; 1998 Feb; 276(3):657-67. PubMed ID: 9551103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomic structure of PI3-kinase SH3 amyloid fibrils by cryo-electron microscopy.
    Röder C; Vettore N; Mangels LN; Gremer L; Ravelli RBG; Willbold D; Hoyer W; Buell AK; Schröder GF
    Nat Commun; 2019 Aug; 10(1):3754. PubMed ID: 31434882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis.
    Polverino de Laureto P; Taddei N; Frare E; Capanni C; Costantini S; Zurdo J; Chiti F; Dobson CM; Fontana A
    J Mol Biol; 2003 Nov; 334(1):129-41. PubMed ID: 14596805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case.
    Ventura S; Zurdo J; Narayanan S; Parreño M; Mangues R; Reif B; Chiti F; Giannoni E; Dobson CM; Aviles FX; Serrano L
    Proc Natl Acad Sci U S A; 2004 May; 101(19):7258-63. PubMed ID: 15123800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid fibril formation by an SH3 domain.
    Guijarro JI; Sunde M; Jones JA; Campbell ID; Dobson CM
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4224-8. PubMed ID: 9539718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils.
    Ventura S; Lacroix E; Serrano L
    J Mol Biol; 2002 Oct; 322(5):1147-58. PubMed ID: 12367534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR characterization of hydrophobic collapses in amyloidogenic unfolded states and their implications for amyloid formation.
    Lim KH; Nagchowdhuri P; Rathinavelan T; Im W
    Biochem Biophys Res Commun; 2010 Jun; 396(4):800-5. PubMed ID: 20438713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR characterizations of an amyloidogenic conformational ensemble of the PI3K SH3 domain.
    Ahn HC; Le YT; Nagchowdhuri PS; Derose EF; Putnam-Evans C; London RE; Markley JL; Lim KH
    Protein Sci; 2006 Nov; 15(11):2552-7. PubMed ID: 17001038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermolecular structure determination of amyloid fibrils with magic-angle spinning and dynamic nuclear polarization NMR.
    Bayro MJ; Debelouchina GT; Eddy MT; Birkett NR; MacPhee CE; Rosay M; Maas WE; Dobson CM; Griffin RG
    J Am Chem Soc; 2011 Sep; 133(35):13967-74. PubMed ID: 21774549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain.
    Zurdo J; Guijarro JI; Jiménez JL; Saibil HR; Dobson CM
    J Mol Biol; 2001 Aug; 311(2):325-40. PubMed ID: 11478864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation.
    Bader R; Bamford R; Zurdo J; Luisi BF; Dobson CM
    J Mol Biol; 2006 Feb; 356(1):189-208. PubMed ID: 16364365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folding dynamics of the src SH3 domain.
    Grantcharova VP; Baker D
    Biochemistry; 1997 Dec; 36(50):15685-92. PubMed ID: 9398297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction and structural characterization of an independently folding substructure in the src SH3 domain.
    Yi Q; Bystroff C; Rajagopal P; Klevit RE; Baker D
    J Mol Biol; 1998; 283(1):293-300. PubMed ID: 9761691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of protonless NMR spectroscopy to alleviate the loss of information resulting from exchange-broadening.
    Hsu ST; Bertoncini CW; Dobson CM
    J Am Chem Soc; 2009 Jun; 131(21):7222-3. PubMed ID: 19432443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of backbone motions in ligand binding to the c-Src SH3 domain.
    Wang C; Pawley NH; Nicholson LK
    J Mol Biol; 2001 Nov; 313(4):873-87. PubMed ID: 11697910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.
    Tessari M; Gentile LN; Taylor SJ; Shalloway DI; Nicholson LK; Vuister GW
    Biochemistry; 1997 Nov; 36(47):14561-71. PubMed ID: 9398174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of the recognition of the SAMP motif of adenomatous polyposis coli by the Src-homology 3 domain.
    Kaieda S; Matsui C; Mimori-Kiyosue Y; Ikegami T
    Biochemistry; 2010 Jun; 49(25):5143-53. PubMed ID: 20509626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.